• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于纳米颗粒清除活性氧的治疗策略在动脉粥样硬化中的进展。

Advances in treatment strategies based on scavenging reactive oxygen species of nanoparticles for atherosclerosis.

机构信息

Department of Thyroid and Vascular Surgery, the Affiliated Hospital of Southwest Medical University, No. 25, Taiping Street, Luzhou, Sichuan, 646000, China.

Department of Thyroid Surgery, people's Hospital of Deyang, Deyang, Sichuan, 618000, China.

出版信息

J Nanobiotechnology. 2023 Aug 17;21(1):271. doi: 10.1186/s12951-023-02058-z.

DOI:10.1186/s12951-023-02058-z
PMID:37592345
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10433664/
Abstract

The development of atherosclerosis (AS) is closely linked to changes in the plaque microenvironment, which consists primarily of the cells that form plaque and the associated factors they secrete. The onset of inflammation, lipid deposition, and various pathological changes in cellular metabolism that accompany the plaque microenvironment will promote the development of AS. Numerous studies have shown that oxidative stress is an important condition that promotes AS. The accumulation of reactive oxygen species (ROS) is oxidative stress's most important pathological change. In turn, the effects of ROS on the plaque microenvironment are complex and varied, and these effects are ultimately reflected in the promotion or inhibition of AS. This article reviews the effects of ROS on the microenvironment of atherosclerotic plaques and their impact on disease progression over the past five years and focuses on the progress of treatment strategies based on scavenging ROS of nanoparticles for AS. Finally, we also discuss the prospects and challenges of AS treatment.

摘要

动脉粥样硬化(AS)的发展与斑块微环境的变化密切相关,斑块微环境主要由形成斑块的细胞和它们分泌的相关因子组成。炎症的发生、脂质的沉积以及伴随斑块微环境的细胞代谢的各种病理变化,将促进 AS 的发展。大量研究表明,氧化应激是促进 AS 的一个重要条件。活性氧(ROS)的积累是氧化应激最重要的病理变化。反过来,ROS 对斑块微环境的影响是复杂多样的,这些影响最终反映在促进或抑制 AS 的发生上。本文综述了 ROS 对动脉粥样硬化斑块微环境的影响及其对疾病进展的影响,重点介绍了近五年来基于纳米颗粒清除 ROS 的 AS 治疗策略的研究进展。最后,我们还讨论了 AS 治疗的前景和挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dede/10433664/282c067dd9cd/12951_2023_2058_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dede/10433664/9bd3a768d3b5/12951_2023_2058_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dede/10433664/bd6aa38fe7fd/12951_2023_2058_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dede/10433664/adb1496b0200/12951_2023_2058_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dede/10433664/282c067dd9cd/12951_2023_2058_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dede/10433664/9bd3a768d3b5/12951_2023_2058_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dede/10433664/bd6aa38fe7fd/12951_2023_2058_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dede/10433664/adb1496b0200/12951_2023_2058_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dede/10433664/282c067dd9cd/12951_2023_2058_Fig4_HTML.jpg

相似文献

1
Advances in treatment strategies based on scavenging reactive oxygen species of nanoparticles for atherosclerosis.基于纳米颗粒清除活性氧的治疗策略在动脉粥样硬化中的进展。
J Nanobiotechnology. 2023 Aug 17;21(1):271. doi: 10.1186/s12951-023-02058-z.
2
Targeted nanoparticles triggered by plaque microenvironment for atherosclerosis treatment through cascade effects of reactive oxygen species scavenging and anti-inflammation.靶向斑块微环境的纳米颗粒通过活性氧清除和抗炎的级联效应治疗动脉粥样硬化。
J Nanobiotechnology. 2024 Jul 27;22(1):440. doi: 10.1186/s12951-024-02652-9.
3
Aortic plaque-targeted andrographolide delivery with oxidation-sensitive micelle effectively treats atherosclerosis via simultaneous ROS capture and anti-inflammation.载药氧化敏感胶束实现靶向主动脉斑块给药,通过同时捕获 ROS 和抗炎治疗动脉粥样硬化。
Nanomedicine. 2018 Oct;14(7):2215-2226. doi: 10.1016/j.nano.2018.06.010. Epub 2018 Jun 30.
4
Non-proinflammatory and responsive nanoplatforms for targeted treatment of atherosclerosis.用于动脉粥样硬化靶向治疗的无炎症反应型响应性纳米平台。
Biomaterials. 2017 Oct;143:93-108. doi: 10.1016/j.biomaterials.2017.07.035. Epub 2017 Jul 29.
5
Pharmacological inhibition of histone deacetylase reduces NADPH oxidase expression, oxidative stress and the progression of atherosclerotic lesions in hypercholesterolemic apolipoprotein E-deficient mice; potential implications for human atherosclerosis.组蛋白去乙酰化酶抑制物可降低载脂蛋白 E 缺陷型高脂血症小鼠的 NADPH 氧化酶表达、氧化应激和动脉粥样硬化病变进展;对人类动脉粥样硬化具有潜在意义。
Redox Biol. 2020 Jan;28:101338. doi: 10.1016/j.redox.2019.101338. Epub 2019 Oct 4.
6
NecroX-7 reduces necrotic core formation in atherosclerotic plaques of Apoe knockout mice.NecroX-7 减少了载脂蛋白 E 基因敲除小鼠动脉粥样硬化斑块中的坏死核心形成。
Atherosclerosis. 2016 Sep;252:166-174. doi: 10.1016/j.atherosclerosis.2016.06.045. Epub 2016 Jul 2.
7
Reactive oxygen species scavenging and inflammation mitigation enabled by biomimetic prussian blue analogues boycott atherosclerosis.仿生普鲁士蓝类似物实现的活性氧清除和炎症减轻可抑制动脉粥样硬化。
J Nanobiotechnology. 2021 May 31;19(1):161. doi: 10.1186/s12951-021-00897-2.
8
Targeted therapy of atherosclerosis by pH-sensitive hyaluronic acid nanoparticles co-delivering all-trans retinal and rapamycin.通过 pH 敏感的透明质酸纳米粒共递送全反式视黄醛和雷帕霉素实现动脉粥样硬化的靶向治疗。
Nanoscale. 2022 Jun 23;14(24):8709-8726. doi: 10.1039/d1nr06514a.
9
Shear Stress and ROS Dual-Responsive RBC-Hitchhiking Nanoparticles for Atherosclerosis Therapy.剪切应力和 ROS 双重响应 RBC 搭便车纳米粒子用于动脉粥样硬化治疗。
ACS Appl Mater Interfaces. 2023 Sep 20;15(37):43374-43386. doi: 10.1021/acsami.3c07371. Epub 2023 Sep 5.
10
Design of a Multifunctional Nanozyme for Resolving the Proinflammatory Plaque Microenvironment and Attenuating Atherosclerosis.多功能纳米酶的设计用于解决促炎斑块微环境并减轻动脉粥样硬化
ACS Nano. 2023 Aug 8;17(15):14555-14571. doi: 10.1021/acsnano.3c01420. Epub 2023 Jun 23.

引用本文的文献

1
Targeted and Biomimetic Nanoparticles for Atherosclerosis Therapy: A Review of Emerging Strategies.用于动脉粥样硬化治疗的靶向及仿生纳米颗粒:新兴策略综述
Biomedicines. 2025 Jul 14;13(7):1720. doi: 10.3390/biomedicines13071720.
2
Targeting oxidative damage in diabetic foot ulcers: integrative strategies involving antioxidant drugs and nanotechnologies.针对糖尿病足溃疡中的氧化损伤:涉及抗氧化药物和纳米技术的综合策略。
Burns Trauma. 2025 Mar 10;13:tkaf020. doi: 10.1093/burnst/tkaf020. eCollection 2025.
3
Nanomedicine in cardiovascular and cerebrovascular diseases: targeted nanozyme therapies and their clinical potential and current challenges.

本文引用的文献

1
Reduction of Reactive Oxygen Species Accumulation Using Gadolinium-Doped Ceria for the Alleviation of Atherosclerosis.用掺钆氧化铈减少活性氧积累缓解动脉粥样硬化。
ACS Appl Mater Interfaces. 2023 Mar 1;15(8):10414-10425. doi: 10.1021/acsami.2c20492. Epub 2023 Feb 19.
2
Nanomaterials and Their Impact on the Immune System.纳米材料及其对免疫系统的影响。
Int J Mol Sci. 2023 Jan 19;24(3):2008. doi: 10.3390/ijms24032008.
3
Anti-Oxidative, Anti-Apoptotic, and M2 Polarized DSPC Liposome Nanoparticles for Selective Treatment of Atherosclerosis.
纳米医学在心血管和脑血管疾病中的应用:靶向纳米酶疗法及其临床潜力与当前挑战。
J Nanobiotechnology. 2025 Jul 28;23(1):543. doi: 10.1186/s12951-025-03590-w.
4
High-Density Lipoprotein Biomimetic Inorganic-Organic Composite Nanosystem for Atherosclerosis Therapy.用于动脉粥样硬化治疗的高密度脂蛋白仿生无机-有机复合纳米系统
Polymers (Basel). 2025 Feb 26;17(5):625. doi: 10.3390/polym17050625.
5
Transcription Factor Blimp-1: A Central Regulator of Oxidative Stress and Metabolic Reprogramming in Chronic Inflammatory Diseases.转录因子Blimp-1:慢性炎症性疾病中氧化应激和代谢重编程的核心调节因子
Antioxidants (Basel). 2025 Feb 4;14(2):183. doi: 10.3390/antiox14020183.
6
Macrophage-based pathogenesis and theranostics of vulnerable plaques.基于巨噬细胞的易损斑块发病机制与诊疗学
Theranostics. 2025 Jan 2;15(4):1570-1588. doi: 10.7150/thno.105256. eCollection 2025.
7
Simultaneously blocking ANGPTL3 and IL-1β for the treatment of atherosclerosis through lipid-lowering and anti-inflammation.通过降脂和抗炎作用同时阻断 ANGPTL3 和 IL-1β 治疗动脉粥样硬化。
Inflamm Res. 2024 Nov;73(11):1931-1944. doi: 10.1007/s00011-024-01941-1. Epub 2024 Sep 10.
8
A Systematic Review on Advances in Management of Oxidative Stress-Associated Cardiovascular Diseases.氧化应激相关心血管疾病管理进展的系统评价
Antioxidants (Basel). 2024 Jul 29;13(8):923. doi: 10.3390/antiox13080923.
9
Oral Nanoformulations in Cardiovascular Medicine: Advances in Atherosclerosis Treatment.心血管医学中的口服纳米制剂:动脉粥样硬化治疗进展
Pharmaceuticals (Basel). 2024 Jul 10;17(7):919. doi: 10.3390/ph17070919.
10
ROS-Induced Endothelial Dysfunction in the Pathogenesis of Atherosclerosis.活性氧诱导的内皮功能障碍在动脉粥样硬化发病机制中的作用
Aging Dis. 2024 Mar 18;16(1):250-68. doi: 10.14336/AD.2024.0309.
抗氧化、抗凋亡及 M2 极化 DSPC 脂质体纳米粒选择性治疗动脉粥样硬化
Int J Nanomedicine. 2023 Feb 1;18:579-594. doi: 10.2147/IJN.S384675. eCollection 2023.
4
Recent advances of tanshinone in regulating autophagy for medicinal research.丹参酮在调节自噬用于医学研究方面的最新进展。
Front Pharmacol. 2023 Jan 12;13:1059360. doi: 10.3389/fphar.2022.1059360. eCollection 2022.
5
Research of Mitochondrial Function, Structure, Dynamics and Intracellular Organization.线粒体功能、结构、动态和细胞内组织的研究。
Int J Mol Sci. 2023 Jan 3;24(1):886. doi: 10.3390/ijms24010886.
6
Messenger Nanozyme for Reprogramming the Microenvironment of Rheumatoid Arthritis.用于重编程类风湿关节炎微环境的信使纳米酶
ACS Appl Mater Interfaces. 2023 Jan 11;15(1):338-353. doi: 10.1021/acsami.2c16458. Epub 2022 Dec 29.
7
Macrophage cell membrane-based nanoparticles: a new promising biomimetic platform for targeted delivery and treatment.基于巨噬细胞膜的纳米粒子:一种用于靶向递药和治疗的新型有前途的仿生平台。
J Nanobiotechnology. 2022 Dec 27;20(1):542. doi: 10.1186/s12951-022-01746-6.
8
M1/M2 re-polarization of kaempferol biomimetic NPs in anti-inflammatory therapy of atherosclerosis.山奈酚仿生纳米粒子在动脉粥样硬化炎症治疗中 M1/M2 型极化的回复作用。
J Control Release. 2023 Jan;353:1068-1083. doi: 10.1016/j.jconrel.2022.12.041. Epub 2022 Dec 22.
9
Advances in imaging and treatment of atherosclerosis based on organic nanoparticles.基于有机纳米颗粒的动脉粥样硬化成像与治疗进展。
APL Bioeng. 2022 Dec 5;6(4):041501. doi: 10.1063/5.0127835. eCollection 2022 Dec.
10
Cell membrane-coated nanoparticles: a novel multifunctional biomimetic drug delivery system.细胞膜包覆的纳米颗粒:一种新型多功能仿生药物传递系统。
Drug Deliv Transl Res. 2023 Mar;13(3):716-737. doi: 10.1007/s13346-022-01252-0. Epub 2022 Nov 22.